Resveratrol Encapsulation and Release from Pristine and Functionalized Mesoporous Silica Carriers

Author's Department

Biology Department

Find in your Library

https://doi.org/10.3390/pharmaceutics14010203

All Authors

Simona Ioniţă, Daniel Lincu, Raul-Augustin Mitran, Laila Ziko, Nada K Sedky, Mihaela Deaconu, Ana-Maria Brezoiu, Cristian Matei, Daniela Berger

Document Type

Research Article

Publication Title

Pharmaceutics

Publication Date

1-16-2022

doi

10.3390/pharmaceutics14010203

Abstract

Resveratrol, a naturally occurring polyphenol, has attracted significant attention due to its antioxidant, cardioprotective and anticancer potential. However, its low aqueous solubility limits resveratrol bioavailability and use. In this work, different mesoporous silica matrices were used to encapsulate the polyphenol and to increase its dissolution rate. Pristine MCM-41, MCM-48, SBA-15, SBA-16, FDU-12 and MCF silica were obtained. The influence of SBA-15 functionalized with aminopropyl, isocyanate, phenyl, mercaptopropyl, and propionic acid moieties on resveratrol loading and release profiles was also assessed. The cytotoxic effects were evaluated for mesoporous carriers and resveratrol-loaded samples against human lung cancer (A549), breast cancer (MDA-MB-231) and human skin fibroblast (HSF) cell lines. The effect on apoptosis and cell cycle were assayed for selected resveratrol-loaded carriers. The polyphenol molecules are encapsulated only inside the mesopores, mostly in amorphous state. All materials containing either pristine or functionalized silica carriers increased polyphenol dissolution rate. The influence of the physico-chemical properties of the mesoporous carriers and resveratrol-loaded supports on the kinetic parameters was identified. Resv@SBA-15-SH and Resv@SBA-15-NCO samples exhibited the highest anticancer effect against A549 cells (IC50 values were 26.06 and 36.5 µg/mL, respectively) and against MDA-MB-231 (IC50 values were 35.56 and 19.30 µg/mL, respectively), which highlights their potential use against cancer.

First Page

1

Last Page

21

This document is currently not available here.

Share

COinS